You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 5, May 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis

S. D. Finkelstein, R. Sayegh, A. Bakker and P. Swalsky
Department of Pathology, Rhode Island Hospital, Brown University, Providence 02903.

Markers that predict tumor aggressiveness on a case-by-case basis would enable individualization and optimization of oncologic therapy. To achieve this goal, the presence and specific type of K-ras-2 point mutation was determined from formalin-fixed, paraffin-embedded tissue sites in 247 primary and 166 metastatic-recurrent colorectal adenocarcinomas, using a novel approach consisting of topographic tissue selection, DNA amplification, and direct sequencing applicable to large and needle-biopsy-sized specimens. The results provide the basis for a genotypic classification of colorectal cancer capable of predicting individual tumor aggressiveness, including the pattern and extent of metastasis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts
Vizan et al.
Cancer Res. 2005;65:5512-5515.
ABSTRACT | FULL TEXT  

Inverse Relationship between Microsatellite Instability and K-ras and p53 Gene Alterations in Colon Cancer
Samowitz et al.
Am. J. Pathol. 2001;158:1517-1524.
ABSTRACT | FULL TEXT  

K-ras Codon 12 Mutation Induces Higher Level of Resistance to Apoptosis and Predisposition to Anchorage-independent Growth Than Codon 13 Mutation or Proto-Oncogene Overexpression
Guerrero et al.
Cancer Res. 2000;60:6750-6756.
ABSTRACT | FULL TEXT  

Relationship of Ki-ras Mutations in Colon Cancers to Tumor Location, Stage, and Survival: A Population-based Study
Samowitz et al.
Cancer Epidemiol. Biomarkers Prev. 2000;9:1193-1197.
ABSTRACT | FULL TEXT  

Mutation Detection in K-ras, BRCA1, BRCA2, and p53 Using PCR/LDR and a Universal DNA Microarray
FAVIS and BARANY
Ann. N. Y. Acad. Sci. 2000;906:39-43.
ABSTRACT | FULL TEXT  

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer
Graziano et al.
JCO 1999;17:668-668.
ABSTRACT | FULL TEXT  

Oncogenic Ki-ras but Not Oncogenic Ha-ras Blocks Integrin beta 1-Chain Maturation in Colon Epithelial Cells
Yan et al.
J. Biol. Chem. 1997;272:30928-30936.
ABSTRACT | FULL TEXT  

Oncogenic c-Ki-ras but Not Oncogenic c-Ha-ras Up-regulates CEA Expression and Disrupts Basolateral Polarity in Colon Epithelial Cells
Yan et al.
J. Biol. Chem. 1997;272:27902-27907.
ABSTRACT | FULL TEXT  

Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer
Jen et al.
NEJM 1994;331:213-221.
ABSTRACT | FULL TEXT  

Differential Activation of the Rac Pathway by Ha-Ras and K-Ras
Walsh and Bar-Sagi
J. Biol. Chem. 2001;276:15609-15615.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.